🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 1 hora
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 20/07/2004 | 12,28 | 12,61 | 12,13 | 12,52 | +3,13% | 3,95% | 425.800 |
| 19/07/2004 | 12,49 | 12,57 | 11,95 | 12,14 | -2,92% | 4,97% | 460.400 |
| 16/07/2004 | 12,54 | 12,67 | 12,40 | 12,50 | +0,04% | 2,11% | 442.200 |
| 15/07/2004 | 12,28 | 12,70 | 12,13 | 12,50 | -0,16% | 4,68% | 379.800 |
| 14/07/2004 | 12,42 | 12,78 | 12,37 | 12,52 | +1,21% | 3,30% | 477.200 |
| 13/07/2004 | 12,30 | 12,53 | 12,28 | 12,37 | +0,69% | 1,99% | 200.800 |
| 12/07/2004 | 12,13 | 12,40 | 12,06 | 12,28 | +1,11% | 2,84% | 331.400 |
| 09/07/2004 | 12,30 | 12,44 | 12,10 | 12,15 | -1,06% | 2,72% | 275.600 |
| 08/07/2004 | 12,38 | 12,55 | 12,25 | 12,28 | -1,60% | 2,46% | 299.400 |
| 07/07/2004 | 12,54 | 12,65 | 12,35 | 12,48 | +0,28% | 2,39% | 130.400 |
| 06/07/2004 | 12,70 | 12,72 | 12,41 | 12,44 | -2,62% | 2,44% | 166.200 |
| 02/07/2004 | 12,70 | 12,84 | 12,70 | 12,78 | -0,20% | 1,10% | 303.400 |
| 01/07/2004 | 12,78 | 13,06 | 12,69 | 12,80 | -0,19% | 2,90% | 706.800 |
| 30/06/2004 | 12,60 | 12,92 | 12,60 | 12,83 | +1,18% | 2,50% | 321.000 |
| 29/06/2004 | 12,48 | 12,70 | 12,48 | 12,68 | +1,40% | 1,72% | 574.800 |
| 28/06/2004 | 12,46 | 12,64 | 12,25 | 12,50 | -1,11% | 3,13% | 418.400 |
| 25/06/2004 | 12,15 | 12,65 | 12,15 | 12,64 | +3,06% | 4,12% | 522.200 |
| 24/06/2004 | 12,04 | 12,45 | 12,01 | 12,27 | +1,24% | 3,65% | 542.600 |
| 23/06/2004 | 11,71 | 12,23 | 11,67 | 12,12 | +2,58% | 4,83% | 377.800 |
| 22/06/2004 | 11,72 | 11,94 | 11,67 | 11,81 | +0,60% | 2,26% | 356.800 |
| 21/06/2004 | 11,85 | 11,93 | 11,73 | 11,74 | -0,09% | 1,69% | 191.000 |
| 18/06/2004 | 11,95 | 12,02 | 11,72 | 11,75 | -1,55% | 2,47% | 674.800 |
| 17/06/2004 | 11,64 | 12,01 | 11,63 | 11,94 | +1,75% | 3,26% | 727.400 |
| 16/06/2004 | 11,31 | 11,74 | 11,22 | 11,73 | +3,35% | 4,60% | 369.000 |
| 15/06/2004 | 11,14 | 11,40 | 11,08 | 11,35 | +1,93% | 2,83% | 256.800 |
| 14/06/2004 | 11,12 | 11,35 | 11,05 | 11,14 | -0,31% | 2,70% | 280.800 |
| 10/06/2004 | 11,57 | 11,58 | 10,96 | 11,17 | -2,74% | 5,36% | 1.013.000 |
| 09/06/2004 | 11,73 | 11,82 | 11,41 | 11,49 | -2,38% | 3,45% | 521.200 |
| 08/06/2004 | 11,84 | 12,06 | 11,76 | 11,77 | -1,51% | 2,53% | 240.200 |
| 07/06/2004 | 12,00 | 12,00 | 11,80 | 11,95 | +0,21% | 1,67% | 236.000 |